Home›People›Tatjana Naranda
Tatjana Naranda

Tatjana Naranda

President, Chief Operating Officer and director at Maxymune Therapeutics.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Jun 3, 2026·Suggest an edit

About Tatjana Naranda

Tatjana Naranda is a president, chief operating officer and director at Maxymune Therapeutics.

Experience

This experience comes from SEC filings. The years are when the filings name Tatjana Naranda in the role, so the role may have started earlier or lasted longer.

Maxymune Therapeutics, Inc.
President, Chief Operating Officer and director
2025 – 2026 · Los Altos, CA
Develops treatments for people with immune system disorders.

Key Colleagues at Startups

The people Tatjana Naranda works with at each company, as listed on that company's latest Form D.

Maxymune Therapeutics, Inc. · Form D/A, Jun 3, 2026
Gordon Ringold
Gordon Ringold
Executive Chairman of the Board

Sources

  1. SECMaxymune Therapeutics, Inc. Form D/A, filed Jun 3, 2026